세계의 임상시험 관리 시스템(CTMS) 시장 보고서(2025년)

Clinical Trial Management System (CTMS) Global Market Report 2025

US $ 4,490 ￦ 6,242,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,023,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,803,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

임상시험 관리 시스템(CTMS) 시장 규모는 향후 수년간 급성장이 전망됩니다. 2029년에는 CAGR 13.7%로 성장할 전망이며, 26억 9,000만 달러로 성장이 예측됩니다. 예측 기간의 성장은 실시간 데이터 액세스 중시, 전자 진료기록카드(EHRS)와의 통합, 가상 및 분산형 임상 시험 증가, 위험 기반 모니터링 중시, 분석 및 AI의 진보에 기인합니다. 예측 기간 주요 동향으로는 규제 컴플라이언스 및 데이터 보안 중시, 적응형 임상시험 디자인 대두, 이해관계자 인게이지먼트를 위한 협조 플랫폼, 원격지 사이트의 모니터링 및 관리, 진화하는 데이터 표준 및 상호 운용성 등을 들 수 있습니다.

분산형 임상시험(DCT) 증가는 향후 수년간 임상시험 관리 시스템(CTMS) 시장의 성장을 가속할 것으로 예측됩니다. 분산형 임상시험은 원격의료 및 지역의 헬스케어 서비스를 활용하는 것으로 기존 임상시험 모델과 달리 환자가 병원을 거점으로 하는 임상시험 시설을 방문할 필요성을 줄이거나 배제합니다. 임상시험 관리 시스템(CTMS)은 모집 및 참가자의 활동을 모니터링하는 데 도움이 되며, 분산형 임상시험 전체의 상세한 모니터링 및 보고를 제공합니다. 예를 들어 2023년 2월 영국을 거점으로 하는 임상시험 및 연구 전문 온라인 출판물인 Clinical Trials Arena는 임상시험에서의 분산화 요소 통합이 2023년 말까지 17% 증가했으며, 2021년 관측된 피크 수준을 상회했다고 보고했습니다. 따라서 분산형 임상시험의 증가는 임상시험 관리 시스템(CTMS) 시장의 확대를 촉진할 것으로 보입니다.

개인화 의료에 대한 수요 급증은 임상시험 관리 시스템(CTMS) 시장의 궤도를 추진하는 또 다른 중요한 요소입니다. 개별화 의료에서는 개인의 유전자 프로파일을 활용하여 질병의 예방, 진단, 치료에 관한 의사결정을 조정합니다. CTMS는 피험자 모집 전략, 프로토콜 디자인, 데이터 수집 방법, 환자 참여 접근법, 데이터 분석 등을 각 환자의 요구에 맞게 커스터마이징함으로써 임상시험 프로세스를 커스터마이징하는 데 매우 중요한 역할을 하고 있습니다. 주목할 만한 것은 개별화의료연합(Personalized Medicine Coalition)에 의한 조사보고서 'Scope and Significance of Progress in 2022'에서 강조된 바와 같이 식품의약국(FDA)은 2022년에 12개의 개별화의약품을 승인했으며, 이는 새롭게 승인된 치료용 분자실체의 약 34%를 차지합니다. 이러한 개별화 의료에 대한 수요의 급증은, 임상시험 관리 시스템(CTMS) 시장의 확대에 크게 기여하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향 및 전략

제4장 시장-금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석 및 전략 분석 프레임워크

• 세계의 임상시험 관리 시스템(CTMS) PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인 및 억제요인)
• 최종 이용 산업의 분석
• 세계의 임상시험 관리 시스템(CTMS) 시장 : 성장률 분석
• 세계의 임상시험 관리 시스템(CTMS) 시장 실적 : 규모 및 성장(2019-2024년)
• 세계의 임상시험 관리 시스템(CTMS) 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
• 세계의 임상시험 관리 시스템(CTMS) 전체 시장 규모(TAM)

제6장 시장 세분화

• 세계의 임상시험 관리 시스템(CTMS) 시장 : 시스템 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 엔터프라이즈 임상시험 관리 시스템
• 현장 임상시험 관리 시스템
• 세계의 임상시험 관리 시스템(CTMS) 시장 : 컴포넌트별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 소프트웨어
• 서비스
• 하드웨어
• 세계의 임상시험 관리 시스템(CTMS) 시장 : 전개별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 웹 기반(온디맨드)
• 라이선스 엔터프라이즈(온프레미스)
• 클라우드 기반(SaaS)
• 세계의 임상시험 관리 시스템(CTMS) 시장 : 최종 사용자별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 주요 제약 생명 공학 기업
• CRO
• 의료기기 제조업체
• 중소규모 제약 생명 공학 기업
• 기타 최종 사용자
• 세계의 임상시험 관리 시스템(CTMS) 시장 : 기업 임상시험 관리 시스템 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 클라우드 기반 솔루션
• 온프레미스 솔루션
• 세계의 임상시험 관리 시스템(CTMS) 시장 : 현장 임상시험 관리 시스템 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 수동 시스템
• 반자동 시스템

제7장 지역별 및 국가별 분석

• 세계의 임상시험 관리 시스템(CTMS) 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 세계의 임상시험 관리 시스템(CTMS) 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도 및 기업 프로파일

• 임상시험 관리 시스템(CTMS) 시장 : 경쟁 구도
• 임상시험 관리 시스템(CTMS) 시장 : 기업 프로파일
  • The International Business Machines Corporation 개요, 제품 및 서비스, 전략 및 재무 분석
  • Oracle Corporation 개요, 제품 및 서비스, 전략 및 재무 분석
  • Laboratory Corporation of America Holdings 개요, 제품 및 서비스, 전략 및 재무 분석
  • IQVIA Holdings Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
  • Wipro Limited 개요, 제품 및 서비스, 전략 및 재무 분석

제31장 기타 주요 기업 및 혁신 기업

• ICON Public Limited Company
• PAREXEL International Corporation
• Veeva Systems Inc.
• Bioclinica Inc.
• Medidata Solutions Inc.
• Calyx.AI
• Clario Medical Imaging Inc.
• Advarra Inc.
• Bio-Optronics Inc.
• MasterControl Inc.
• ERT Clinical
• iWeb Technologies Limited
• Anju Software Inc.
• Axiom Real-Time Metrics
• EClinForce Inc.

제32장 세계 시장 경쟁 벤치마킹 및 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문 및 전략

• 임상시험 관리 시스템(CTMS) 시장 : 새로운 기회를 제공하는 국가(2029년)
• 임상시험 관리 시스템(CTMS) 시장 : 새로운 기회를 제공하는 부문(2029년)
• 임상시험 관리 시스템(CTMS) 시장 : 성장 전략(2029년)
  • 시장 동향에 기초한 전략
  • 경쟁 전략

제36장 부록

AJY

영문 목차

영문목차

A Clinical Trial Management System (CTMS) serves as a software platform specifically designed to streamline and enhance the management of clinical trials. This comprehensive solution is geared towards centralizing, organizing, and automating various facets of the clinical trial process, thereby facilitating efficient study planning, execution, monitoring, and reporting.

Two primary categories of Clinical Trial Management Systems are enterprise-based and site-based. An enterprise-based CTMS is a software solution implemented and utilized across an entire organization or enterprise. It serves as a centralized platform for managing all clinical trials conducted by the organization. The key components of a CTMS encompass software, services, and hardware, which are delivered through cloud-based, web-based, and on-premises modes. These solutions cater to the needs of pharmaceutical and biopharmaceutical companies, medical device manufacturers, clinical research organizations (CROs), and various other end-users involved in the clinical trial ecosystem.

The clinical trials management system (CTMS) research report is one of a series of new reports from The Business Research Company that provides clinical trials management system (CTMS) market statistics, including the clinical trials management system (CTMS)'s global market size, regional shares, competitors with a clinical trials management system (CTMS) market share, detailed clinical trials management system (CTMS) market segments, market trends and opportunities, and any further data you may need to thrive in the clinical trials management system (CTMS). This clinical trials management system (CTMS) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The clinical trial management system (CTMS) market size has grown rapidly in recent years. It will grow from $1.41 billion in 2024 to $1.61 billion in 2025 at a compound annual growth rate (CAGR) of 14.2%. The growth in the historic period can be attributed to increasing clinical trial complexity, rise in global clinical trials, stringent regulatory compliance, growing focus on patient-centric trials, increasing outsourcing of clinical trials.

The clinical trial management system (CTMS) market size is expected to see rapid growth in the next few years. It will grow to $2.69 billion in 2029 at a compound annual growth rate (CAGR) of 13.7%. The growth in the forecast period can be attributed to emphasis on real-time data access, integration with electronic health records (EHRS), rise in virtual and decentralized trials, focus on risk-based monitoring, advancements in analytics and ai. Major trends in the forecast period include focus on regulatory compliance and data security, rise of adaptive clinical trial designs, collaborative platforms for stakeholder engagement, remote site monitoring and management, evolving data standards and interoperability.

The rise in decentralized clinical trials (DCTs) is anticipated to drive the growth of the clinical trial management system (CTMS) market in the coming years. Decentralized clinical trials utilize telemedicine and local healthcare services to reduce or eliminate the need for patients to visit hospital-based trial sites, unlike traditional clinical trial models. A clinical trial management system (CTMS) helps monitor recruitment and participant activities, offering detailed oversight and reporting throughout decentralized trials. For example, in February 2023, Clinical Trials Arena, a UK-based online publication specializing in clinical trials and research, reported that the integration of decentralization elements in clinical trials is expected to grow by 17% by the end of 2023, surpassing the peak levels observed in 2021. Therefore, the growing number of decentralized clinical trials will fuel the expansion of the clinical trial management system (CTMS) market.

The burgeoning demand for personalized medicine stands as another key factor propelling the trajectory of the clinical trial management system (CTMS) market. Personalized medicine involves leveraging an individual's genetic profile to tailor decisions regarding disease prevention, diagnosis, and treatment. CTMS plays a pivotal role in customizing the clinical trial process by adapting recruitment strategies, protocol designs, data collection methods, patient engagement approaches, and data analysis to suit the specific needs of each patient. Notably, as highlighted in the Scope and Significance of Progress in 2022 report by the Personalized Medicine Coalition, the Food and Drug Administration (FDA) approved 12 personalized medicines in 2022, accounting for approximately 34% of all newly approved therapeutic molecular entities. This surge in demand for personalized medicine significantly contributes to the expansion of the clinical trial management system (CTMS) market.

Key industry players in the clinical trial management system (CTMS) arena are driving innovation by introducing new technological platforms, particularly Software as a Service (SaaS) solutions integrated with artificial intelligence, to expedite drug development processes. SaaS-based CTMS represents a cloud-hosted software platform specifically designed to efficiently manage and oversee various facets of clinical trials. This approach enables accessibility from any location with an internet connection, diminishing the necessity for local software installations and streamlining maintenance efforts. For instance, in June 2023, Saama Technologies, Inc., a prominent US-based provider of clinical development software and services, unveiled a unified platform comprising SaaS-based products complementing their existing artificial intelligence and machine learning-based solutions. This innovative platform streamlines clinical development and commercialization processes by automating critical CTMS functions, slashing query generation times by up to 90%, and significantly reducing study data transformation and analysis durations. It provides a consolidated interface offering comprehensive insights into trial operations and patient progress, consolidating essential information into a singular, easily accessible location.

In August 2023, Sitero, a US-based clinical research organization specializing in clinical trial solutions, acquired Clario for an undisclosed amount. This strategic acquisition underscores Sitero's commitment to innovation and its focus on providing exceptional, technology-driven support and services to clients. Clario, a US-based company, specializes in clinical trial management and offers endpoint data solutions for the clinical trials industry.

Major companies operating in the clinical trial management system (CTMS) market report are The International Business Machines Corporation, Oracle Corporation, Laboratory Corporation of America Holdings, IQVIA Holdings Inc., Wipro Limited, ICON Public Limited Company, PAREXEL International Corporation, Veeva Systems Inc., Bioclinica Inc., Medidata Solutions Inc., Calyx.ai, Clario Medical Imaging Inc., Advarra Inc., Bio-Optronics Inc., MasterControl Inc., ERT Clinical, iWeb Technologies Limited, Anju Software Inc., Axiom Real-Time Metrics, EClinForce Inc., MedNet Solutions Inc., DSG Inc., ArisGlobal LLC, DZS Clinical Services Inc., Datatrak International Inc., Nextrials Nc., SimpleTrials, PHARMASEAL International Limited, Crucial Data Solutions Inc., RealTime Software Solutions LLC

North America was the largest region in the clinical trial management system (CTMS) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical trial management system (ctms) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the clinical trial management system (ctms) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The clinical trial management system (CTMS) market includes revenues earned by entities by providing services such as study planning and design, site selection and management, patient recruitment and enrollment, clinical data management, and monitoring and reporting. The market value includes the value of related goods sold by the service provider or included within the service offering. The clinical trial management system (CTMS) market also includes sales of clinical trial analytics tools and mobile applications that are used in providing clinical trial management services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Clinical Trial Management System (CTMS) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on clinical trial management system (ctms) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for clinical trial management system (ctms) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The clinical trial management system (ctms) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By System Type: Enterprise Clinical Trial Management System; On-Site Clinical Trial Management System
• 2) By Component: Software; Service; Hardware
• 3) By Delivery: Web-Based (On-Demand); Licensed Enterprise (On-Premises); Cloud-Based (SaaS)
• 4) By End User: Large Pharma-Biotech Companies; CROs; Medical Device Manufacturers; Small And Mid-Sized Pharma-Biotech Companies; Other End Users
• Subsegments:
• 1) By Enterprise Clinical Trial Management System: Cloud-Based Solutions; On-Premises Solutions
• 2) By On-Site Clinical Trial Management System: Manual Systems; Semi-Automated Systems
• Companies Mentioned: The International Business Machines Corporation; Oracle Corporation; Laboratory Corporation of America Holdings; IQVIA Holdings Inc.; Wipro Limited
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Clinical Trial Management System (CTMS) Market Characteristics

3. Clinical Trial Management System (CTMS) Market Trends And Strategies

4. Clinical Trial Management System (CTMS) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Clinical Trial Management System (CTMS) Growth Analysis And Strategic Analysis Framework

• 5.1. Global Clinical Trial Management System (CTMS) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Clinical Trial Management System (CTMS) Market Growth Rate Analysis
• 5.4. Global Clinical Trial Management System (CTMS) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Clinical Trial Management System (CTMS) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Clinical Trial Management System (CTMS) Total Addressable Market (TAM)

6. Clinical Trial Management System (CTMS) Market Segmentation

• 6.1. Global Clinical Trial Management System (CTMS) Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Enterprise Clinical Trial Management System
• On-Site Clinical Trial Management System
• 6.2. Global Clinical Trial Management System (CTMS) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Software
• Service
• Hardware
• 6.3. Global Clinical Trial Management System (CTMS) Market, Segmentation By Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Web-Based (On-Demand)
• Licensed Enterprise (On-Premises)
• Cloud-Based (SaaS)
• 6.4. Global Clinical Trial Management System (CTMS) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Large Pharma-Biotech Companies
• CROs
• Medical Device Manufacturers
• Small And Mid-Sized Pharma-Biotech Companies
• Other End Users
• 6.5. Global Clinical Trial Management System (CTMS) Market, Sub-Segmentation Of Enterprise Clinical Trial Management System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cloud-Based Solutions
• On-Premises Solutions
• 6.6. Global Clinical Trial Management System (CTMS) Market, Sub-Segmentation Of On-Site Clinical Trial Management System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Manual Systems
• Semi-Automated Systems

7. Clinical Trial Management System (CTMS) Market Regional And Country Analysis

• 7.1. Global Clinical Trial Management System (CTMS) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Clinical Trial Management System (CTMS) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Clinical Trial Management System (CTMS) Market

• 8.1. Asia-Pacific Clinical Trial Management System (CTMS) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Clinical Trial Management System (CTMS) Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Clinical Trial Management System (CTMS) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Clinical Trial Management System (CTMS) Market, Segmentation By Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Clinical Trial Management System (CTMS) Market

• 9.1. China Clinical Trial Management System (CTMS) Market Overview
• 9.2. China Clinical Trial Management System (CTMS) Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Clinical Trial Management System (CTMS) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Clinical Trial Management System (CTMS) Market, Segmentation By Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Clinical Trial Management System (CTMS) Market

• 10.1. India Clinical Trial Management System (CTMS) Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Clinical Trial Management System (CTMS) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Clinical Trial Management System (CTMS) Market, Segmentation By Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Clinical Trial Management System (CTMS) Market

• 11.1. Japan Clinical Trial Management System (CTMS) Market Overview
• 11.2. Japan Clinical Trial Management System (CTMS) Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Clinical Trial Management System (CTMS) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Clinical Trial Management System (CTMS) Market, Segmentation By Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Clinical Trial Management System (CTMS) Market

• 12.1. Australia Clinical Trial Management System (CTMS) Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Clinical Trial Management System (CTMS) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Clinical Trial Management System (CTMS) Market, Segmentation By Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Clinical Trial Management System (CTMS) Market

• 13.1. Indonesia Clinical Trial Management System (CTMS) Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Clinical Trial Management System (CTMS) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Clinical Trial Management System (CTMS) Market, Segmentation By Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Clinical Trial Management System (CTMS) Market

• 14.1. South Korea Clinical Trial Management System (CTMS) Market Overview
• 14.2. South Korea Clinical Trial Management System (CTMS) Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Clinical Trial Management System (CTMS) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Clinical Trial Management System (CTMS) Market, Segmentation By Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Clinical Trial Management System (CTMS) Market

• 15.1. Western Europe Clinical Trial Management System (CTMS) Market Overview
• 15.2. Western Europe Clinical Trial Management System (CTMS) Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Clinical Trial Management System (CTMS) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Clinical Trial Management System (CTMS) Market, Segmentation By Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Clinical Trial Management System (CTMS) Market

• 16.1. UK Clinical Trial Management System (CTMS) Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Clinical Trial Management System (CTMS) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Clinical Trial Management System (CTMS) Market, Segmentation By Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Clinical Trial Management System (CTMS) Market

• 17.1. Germany Clinical Trial Management System (CTMS) Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Clinical Trial Management System (CTMS) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Clinical Trial Management System (CTMS) Market, Segmentation By Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Clinical Trial Management System (CTMS) Market

• 18.1. France Clinical Trial Management System (CTMS) Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Clinical Trial Management System (CTMS) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Clinical Trial Management System (CTMS) Market, Segmentation By Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Clinical Trial Management System (CTMS) Market

• 19.1. Italy Clinical Trial Management System (CTMS) Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Clinical Trial Management System (CTMS) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Clinical Trial Management System (CTMS) Market, Segmentation By Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Clinical Trial Management System (CTMS) Market

• 20.1. Spain Clinical Trial Management System (CTMS) Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Clinical Trial Management System (CTMS) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Clinical Trial Management System (CTMS) Market, Segmentation By Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Clinical Trial Management System (CTMS) Market

• 21.1. Eastern Europe Clinical Trial Management System (CTMS) Market Overview
• 21.2. Eastern Europe Clinical Trial Management System (CTMS) Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Clinical Trial Management System (CTMS) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Clinical Trial Management System (CTMS) Market, Segmentation By Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Clinical Trial Management System (CTMS) Market

• 22.1. Russia Clinical Trial Management System (CTMS) Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Clinical Trial Management System (CTMS) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Clinical Trial Management System (CTMS) Market, Segmentation By Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Clinical Trial Management System (CTMS) Market

• 23.1. North America Clinical Trial Management System (CTMS) Market Overview
• 23.2. North America Clinical Trial Management System (CTMS) Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Clinical Trial Management System (CTMS) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Clinical Trial Management System (CTMS) Market, Segmentation By Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Clinical Trial Management System (CTMS) Market

• 24.1. USA Clinical Trial Management System (CTMS) Market Overview
• 24.2. USA Clinical Trial Management System (CTMS) Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Clinical Trial Management System (CTMS) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Clinical Trial Management System (CTMS) Market, Segmentation By Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Clinical Trial Management System (CTMS) Market

• 25.1. Canada Clinical Trial Management System (CTMS) Market Overview
• 25.2. Canada Clinical Trial Management System (CTMS) Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Clinical Trial Management System (CTMS) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Clinical Trial Management System (CTMS) Market, Segmentation By Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Clinical Trial Management System (CTMS) Market

• 26.1. South America Clinical Trial Management System (CTMS) Market Overview
• 26.2. South America Clinical Trial Management System (CTMS) Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Clinical Trial Management System (CTMS) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Clinical Trial Management System (CTMS) Market, Segmentation By Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Clinical Trial Management System (CTMS) Market

• 27.1. Brazil Clinical Trial Management System (CTMS) Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Clinical Trial Management System (CTMS) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Clinical Trial Management System (CTMS) Market, Segmentation By Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Clinical Trial Management System (CTMS) Market

• 28.1. Middle East Clinical Trial Management System (CTMS) Market Overview
• 28.2. Middle East Clinical Trial Management System (CTMS) Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Clinical Trial Management System (CTMS) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Clinical Trial Management System (CTMS) Market, Segmentation By Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Clinical Trial Management System (CTMS) Market

• 29.1. Africa Clinical Trial Management System (CTMS) Market Overview
• 29.2. Africa Clinical Trial Management System (CTMS) Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Clinical Trial Management System (CTMS) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Clinical Trial Management System (CTMS) Market, Segmentation By Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Clinical Trial Management System (CTMS) Market Competitive Landscape And Company Profiles

• 30.1. Clinical Trial Management System (CTMS) Market Competitive Landscape
• 30.2. Clinical Trial Management System (CTMS) Market Company Profiles
  • 30.2.1. The International Business Machines Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Oracle Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. IQVIA Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Wipro Limited Overview, Products and Services, Strategy and Financial Analysis

31. Clinical Trial Management System (CTMS) Market Other Major And Innovative Companies

• 31.1. ICON Public Limited Company
• 31.2. PAREXEL International Corporation
• 31.3. Veeva Systems Inc.
• 31.4. Bioclinica Inc.
• 31.5. Medidata Solutions Inc.
• 31.6. Calyx.ai
• 31.7. Clario Medical Imaging Inc.
• 31.8. Advarra Inc.
• 31.9. Bio-Optronics Inc.
• 31.10. MasterControl Inc.
• 31.11. ERT Clinical
• 31.12. iWeb Technologies Limited
• 31.13. Anju Software Inc.
• 31.14. Axiom Real-Time Metrics
• 31.15. EClinForce Inc.

32. Global Clinical Trial Management System (CTMS) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Clinical Trial Management System (CTMS) Market

34. Recent Developments In The Clinical Trial Management System (CTMS) Market

35. Clinical Trial Management System (CTMS) Market High Potential Countries, Segments and Strategies

• 35.1 Clinical Trial Management System (CTMS) Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Clinical Trial Management System (CTMS) Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Clinical Trial Management System (CTMS) Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료